AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

SPORIDEX DEGROWS AT 10.1%; NEUROBION STILL AHEAD. [2 TABLES] (Ranbaxy Laboratories Ltd's sporidex has reported the highest degrowth of 10.1%).

Asia Africa Intelligence Wire

| July 24, 2003 | COPYRIGHT 2003 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From India Business Insight)

Ranbaxy Laboratories Ltd's Sporidex has reported the highest degrowth of 10.1%, with sales of Rs623.3 M, among the top ten brands of pharmaceuticals for twelve months ending May 2003.

The Rs183.4 M industry as such has reported a growth of 4.4%. On the other hand, Neurobion vitamin, the flagship brand of Merck Ltd, continues to achieve the highest growth rate among the top ten ...

Related articles from newspapers, magazines, journals, and more
Ranbaxy Laboratories Limited Selected to Present Metformin Research at the...
Press release article from: PR Newswire April 30, 2004 700+ words
...a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has been selected...Kiran Marthak, Vice-president of Ranbaxy Laboratories Limited, Medical Affairs and Clinical...is the wholly owned subsidiary of Ranbaxy Laboratories Limited ("RLL"), India's...
Research and Markets: View a Detailed Listing of All Ranbaxy Laboratories Deals...
Press release article from: Business Wire June 23, 2006 700+ words
...announced the addition of "Ranbaxy Laboratories Limited Deals Briefing...offering. Partneringdesk Ranbaxy Laboratories Ltd Deals Briefing provides...of the 37 deals made by Ranbaxy Laboratories Ltd and its subsidiaries...
Ranbaxy Laboratories Ltd. posts 21 percent first half profit gain.
Press release article from: Business Wire October 15, 1996 700+ words
...exports, 23 percent growth in sales Ranbaxy Laboratories, Ltd. (GDR:RBXD-London...will report an operating surplus. Ranbaxy Laboratories Ltd., headquartered in New Delhi...gastrointestinaldrugs. -0- RANBAXY LABORATORIES Unaudited Financial Results (Provisional...
Ranbaxy Laboratories adopts the depository system for its shares.
Press release article from: Business Wire February 18, 1997 700+ words
...WIRE)--February 18, 1997--Ranbaxy Laboratories, Ltd. (GDR:RBXD-London...associated with the transfer of shares. Ranbaxy Laboratories Ltd., headquartered in New Delhi...gastrointestinal drugs. CONTACT: Ranbaxy Laboratories Ltd. V.K. Kaul Vice President...
RANBAXY LABORATORIES LTD. REGISTERS 99 PERCENT INCREASE IN PROFITS FOR YEAR-END...
Press release article from: Business Wire May 9, 1995 700+ words
...1995--The Board of Directors of Ranbaxy Laboratories Limited (GDR: RBXYG) at their...direct exports across the world. Ranbaxy Laboratories Limited has a presence in 40 countries...international pharmaceutical company. -0- Ranbaxy Laboratories Limited Unaudited Financial Results...
Press Statement Issued by Ranbaxy Laboratories Limited.
Press release article from: PR Newswire February 25, 2009 700+ words
...some First to File applications. Ranbaxy Laboratories Limited, India's largest pharmaceutical...Global Corporate Communications Ranbaxy Laboratories Ltd. Plot 90, Sector 32, Gurgaon...Director - Corporate Communications Ranbaxy Laboratories Ltd. Plot 90, Sector 32, Gurgaon...
Ranbaxy Laboratories, Ltd., Retains Former New York City Mayor Rudy Giuliani to...
Press release article from: PR Newswire September 17, 2008 700+ words
...Sept. 17 /PRNewswire/ -- Ranbaxy Laboratories Ltd., today announced that they...Global Corporate Communications Ranbaxy Laboratories Ltd. Plot 90, Sector 32, Gurgaon...Director-Corporate Communications Ranbaxy Laboratories Ltd. Plot 90, Sector 32, Gurgaon...
Ranbaxy Laboratories Ltd to bring in Daiichi Sankyo Company Limited as Majority...
News wire article from: Fair Disclosure Wire June 11, 2008 700+ words
...this conference. Welcome to the Ranbaxy Laboratories conference call. For the duration...ANURAG KALRA, SENIOR MANAGER, IR, RANBAXY LABORATORIES: Good evening and good morning...MALVINDER MOHAN SINGH, CEO AND MD, RANBAXY LABORATORIES: A very good day to all of you...
RANBAXY LABORATORIES: SAFE PRESCRIPTION (higher realisation in overseas markets...
News wire article from: Asia Africa Intelligence Wire July 21, 2002 700+ words
...India Business Insight) Ranbaxy Laboratories recorded a net profit...2001. The business of Ranbaxy Laboratories in the US market has...sales of formulations of Ranbaxy Laboratories in the US market, which...
Ranbaxy Laboratories: Striving for right chemistry, operating profits up for...
News wire article from: Asia Africa Intelligence Wire October 24, 2004 700+ words
...Business NewsBase - Business Line) Ranbaxy Laboratories recorded a 21% increase in operating...brands of the company in the US. Ranbaxy Laboratories expects revenues of $52 M from...abbreviated new drug applications filed by Ranbaxy Laboratories. The company has a significant...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA